Zsa Zsa Weerts

Smart Data Collection for the Assessment of Treatment Effects in IBS 229 9 References 1. Lovell R, Ford A. Global prevalence of and risk factors for irritable bowel syndrome: a meta- analysis. Clin Gastroenterol Hepatol 2012:10:712-721 e714. 2. European Medicines Agency (EMA). Guideline on the evaluation of medicinal products for the treatment of irritable bowel syndrome. CHMP/60337. 2013. 3. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for Industry - Clinical Evaluation of Drugs for Treatment. 2012. 4. Stone AA, Schwartz JE, Broderick JE, et al. Variability of momentary pain predicts recall of weekly pain: a consequence of the peak (or salience) memory heuristic. Pers Soc Psychol Bull 2005;31:1340-1346. 5. Stone AA, S, S, Schwartz JE, et al. Patient compliance with paper and electronic diaries. 2003. 6. Lauritsen K, Degl' Innocenti A, Hendel L, et al. Symptom recording in a randomised clinical trial: paper diaries vs. electronic or telephone data capture. Control Clin Trials 2004;25:585- 597. 7. Stone AA, Shiffman S, Schwartz JE, et al. Patient non-compliance with paper diaries. BMJ 2002;324:1193-1194. 8. Mujagic Z, Keszthelyi D, Aziz Q, et al. Systematic review: instruments to assess abdominal pain in irritable bowel syndrome. Aliment Pharmacol Ther 2015;42:1064-1081. 9. Riaz MS, Atreja A. Personalized Technologies in Chronic Gastrointestinal Disorders: Self- monitoring and Remote Sensor Technologies. Clin Gastroenterol Hepatol 2016;14:1697- 1705. 10. Dennison L, Morrison L, Conway G, et al. Opportunities and challenges for smartphone applications in supporting health behavior change: qualitative study. J Med Internet Res 2013;15:e86. 11. Toivonen KI, Zernicke K, Carlson LE. Web- Based Mindfulness Interventions for People With Physical Health Conditions: Systematic Review. J Med Internet Res 2017;19:e303. 12. Kheirkhahan M, Nair S, Davoudi A, et al. A Smartwatch-Based Framework for Real-Time and Online Assessment and Mobility Monitoring, Journal of Biomedical Informatics. 2018;DOI https://doi.org/10.1016/j.jbi.2018.11.003. 13. Dale O, Hagen KB. Despite technical problems personal digital assistants outperform pen and paper when collecting patient diary data. J Clin Epidemiol 2007;60:8- 17. 14. Burton C, Weller D, Sharpe M. Are electronic diaries useful for symptoms research? A systematic review. J Psychosom Res 2007;62:553-561. 15. Morren M, van Dulmen S, Ouwerkerk J, et al. Compliance with momentary pain measurement using electronic diaries: a systematic review, Eur J Pain 2009;13:354-365. 16. Weerts Z, Masclee A, Witteman B, et al. Efficacy and Safety of Peppermint Oil in a Randomized Double-blind Trial of Patients With Irritable Bowel Syndrome, Gastroenterology. 2019;DOI 10.1053/j.gastro.2019.08.026. 17. Ono M, Schneider S, Junghaenel DU, et al. What Affects the Completion of Ecological Momentary Assessments in Chronic Pain Research? An Individual Patient Data Meta- Analysis. J Med Internet Res 2019;21:e11398. 18. Ernsting C, Dombrowski SU, Oedekoven M, et al. Using Smartphones and Health Apps to Change and Manage Health Behaviors: A Population-Based Survey. J Med Internet Res 2017;19:e101. 19. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013;DOI 10.1001/jama.2013.281053. 20. Versteegh M, Vermeulen K, Evers S. Dutch Tariff for the Five-Level Version of EQ-5D. Value Health 2016;19:343-352. 21. Netherlands, S. Internet; toegang, gebruik en faciliteiten See http://statline.cbs.nl/Statweb/publication/?V W=T&DM=SLNL&PA=83429NED&D1=0,2- 5&D2=0,3-6&D3=0&D4=a&HD=190508- 1455&HDR=T&STB=G1,G2,G3 for further details. 2019. 22. Zia J, Schroeder J, Munson S, et al. Feasibility and Usability Pilot Study of a Novel Irritable Bowel Syndrome Food and Gastrointestinal